logo

Target (TGT) To Offer Flu Vaccination
By: Zacks Investment Research   Tuesday, September 08, 2009 2:10 PM

Vote for next session
The next market session will close:

Target Corp. (TGT) recently said that reasonably priced seasonal flu vaccinations will now be readily available at its 22 Target Clinic locations in Minnesota. The cost of flu vaccines start at only $24, while pneumonia vaccination will be obtainable for $35. The company also said that from October, vaccines would be available at more than 1,500 Target Pharmacy locations.

Although these vaccines do not safeguard against the deadly H1N1 flu, these are essential to protect families against seasonal flu and are recommended by Centers for Disease Control and Prevention. Local, state and federal health authorities are currently administering the production and distribution of H1N1 vaccine.

More than 200,000 people suffer from seasonal flu in the U.S. every year. The target group falls within the age bracket of 6 months to 19 years and 50 years or above, pregnant women, people with chronic diseases, individuals admitted to nursing homes, workers in health care departments and caretakers of children less than six months old.

Target operates general merchandise and food discount stores in the United States. Currently, the company operates 1,719 stores in 49 states.

Kroger Co. (KR) had earlier made seasonal flu vaccines available at its 1,900 stores, effective September. The company operates supermarkets stores in the U.S. under four models – combo store (including both food and drug), multi-department stores, marketplace stores, and price impact warehouses. The company currently operates 2,475 supermarkets and multi-department stores in 31 states.


(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Popular Articles
Related Press Releases
Advertisement
Partner Center
Recent Articles by Zacks Investment Research



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia